Persistance of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse

被引：0

作者：

Janni, Wolfgang ^{[1
]}

Rack, Brigitte ^{[1
]}

Schindlbeck, Christian ^{[1
]}

Strobl, Barbara ^{[1
]}

Rjosk, Dorothea ^{[1
]}

Sommer, Harald ^{[1
]}

Gerber, Bernd ^{[1
]}

Pantel, Klaus ^{[2
]}

Braun, Stephan ^{[3
]}

Friese, Klaus ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Frauenklin Innerstadt, Munich, Germany

[2] UKE Hamburg, Inst Tumorbiol, Hamburg, Germany

[3] Leopold Franzens Univ Innsbruck, Frauenklin, Innsbruck, Austria

来源：

ANNALS OF ONCOLOGY | 2004年 / 15卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：59 / 59

页数：1

共 50 条

[1] Persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse
不详
BREAST, 2005, 14 : S26 - S26
[2] Persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse
Janni, W
Rack, B
Schindlbeck, C
Sommer, H
Gerber, B
Heinrigs, A
Braun, S
Strobl, B
Pantel, K
Friese, K
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S227 - S227
[3] Association of persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients with risk for relapse
Janni, W
Rack, B
Schindlbeck, C
Strobl, B
Rjosk, D
Braun, S
Sommer, H
Pantel, K
Gerber, B
Friese, K
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 22S - 22S
[4] Persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse - results of pooled European data.
Janni, W
Wiedswang, G
Borgen, E
Braun, S
Rack, B
Schindlbeck, C
Sommer, H
Pantel, K
Heinrigs, M
Gerber, B
Nesland, JM
Scholz, C
Friese, K
Jeschke, U
Naume, B
BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S44 - S44
[5] Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients with breast cancer
Rack, Brigitte K.
Janni, Wolfgang
Schoberth, Alexandra
Schindlbeck, Christian
Strobl, Barbara
Heinrigs, Maja
Blankenstein, Thomas
Kentenich, Christina
Sommer, Harald
Friese, Klaus
ANNALS OF ONCOLOGY, 2004, 15 : 102 - 102
[6] Persistence of isolated tumor cells in the bone marrow of breast cancer patients predicts increased risk for relapse - a European pooled analysis
Naume, B.
Fehm, T.
Wiedswang, G.
Juecksock, J.
Borgen, E.
Rack, B.
Synnestvedt, M.
Braun, S.
Sommer, H.
Solomayer, E.
Pantel, K.
Friese, K.
Janni, W.
CANCER RESEARCH, 2009, 69 (02) : 90S - 90S
[7] Persistence of disseminated tumor cells (DTC) in bone marrow (BM) of breast cancer patients predicts increased risk for relapse - Results of pooled European data.
Janni, W. J.
Wiedswang, G.
Fehm, T.
Jueckstock, J.
Borgen, E.
Rack, B.
Braun, S.
Sommer, H.
Pantel, K.
Naume, B.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 561S - 561S
[8] Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients without recurrence of early breast cancer.
Rack, BK
Janni, W
Schoberth, A
Schindbeck, C
Strobl, B
Blankenstein, T
Rjosk, D
Heinrigs, M
Sommer, H
Friese, K
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 838S - 838S
[9] Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse-A European Pooled Analysis
Janni, Wolfgang
Vogl, Florian D.
Wiedswang, Gro
Synnestvedt, Marit
Fehm, Tanja
Jueckstock, Julia
Borgen, Elin
Rack, Brigitte
Braun, Stephan
Sommer, Harald
Solomayer, Erich
Pantel, Klaus
Nesland, Jahn
Friese, Klaus
Naume, Bjorn
CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2967 - 2976
[10] Secondary adjuvant therapy with zoledronate in patients with early breast cancer: is there an effect on persisting isolated tumor cells (ITC) in the bone marrow (BM)?
Rack, BK
Janni, W
Schoberth, A
Heinrigs, M
Schindlbeck, C
Strobl, B
Blankenstein, T
Sommer, H
Friese, KI
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S228 - S228

← 1 2 3 4 5 →